Annual Report 2004, Baker Heart Research Institute

Total Page:16

File Type:pdf, Size:1020Kb

Annual Report 2004, Baker Heart Research Institute HealthHealth meansthe meansthe worldworld tous. tous. 66.320 23.50 0 0 23.50 66.320 baker heart research institute annual report 2004 MISSION Cardiovascular disease is the leading cause of death and disability worldwide and is responsible for over 40% of deaths in Australia each year.The risk factors for cardiovascular disease are highly prevalent in the Australian community with 80% of all adults having one of the following risk factors: Smoking Inactivity High blood pressure Obesity Diabetes Depression Social isolation High Cholesterol At the Baker, our mission is to reduce death and disability from cardiovascular disease.We achieve this through activities ranging from research at the laboratory bench to clinical trials, patient care and education. The major areas of research at the Baker are: • The risk factors and prevention of heart disease and stroke • Coronary disease, heart attack and sudden coronary death • Heart failure • Diabetes and its complications The Baker Heart Research Institute is funded from a diverse range of government and private sources.We remain grateful for the continuing support of the corporate sector, trusts, foundations and individual donations. 2 CONTENTS ABOUT THE BAKER 4 A WORD FROM OUR PATRON 4 PRESIDENT’S REPORT 5 DIRECTOR’S REPORT 8 ORGANISATION STRUCTURE 11 INTERNATIONAL SCIENTISTS 12 SCIENTIFIC OVERVIEW HEART - Cardiology Division 14 BRAIN - Cardiovascular Neuroscience Division 15 VESSELS - Vascular Division 17 CORE FACILITIES 19 GRADUATING STUDENTS 22 COMMERCIALISATION & BUSINESS DEVELOPMENT 24 THE BAKER RESEARCH FOUNDATION 25 BOARD OF MANAGEMENT 26 BAKER SUPPORTERS 27 STAFF 28-31 FINANCIAL REPORT 32-34 PUBLICATIONS 35-38 SUPPORTING THE BAKER 39 www.baker.edu.au 3 ABOUT THE BAKER The Baker leads the fight against now take for granted. For example, Baker The Baker is a World Health heart disease. Cardiovascular disease is scientists proved that exercise lowers blood Organisation Centre for Australia’s leading health problem as over pressure and they discovered the plasma Cardiovascular Research & Training. 3.6 million Australians suffered from protein that distinguishes between Type I Although we are one of the best cardiovascular disease in 2001. Over the and Type II diabetes. In the future, it is the research facilities in the world, we last decade the prevalence of Baker’s vision to eradicate heart disease. recognise that the fight starts at cardiovascular disease rose by more than The Baker boasts 3 major divisions, home. The Baker is actively 18%, and at a cost of 7 billion dollars 24 research laboratories and more involved in the local community each year, it demands 11% of Australia’s than 220 staff. We focus on both basic and sets it sights on becoming total health care expenditure. and clinical research, a unique and a household name. effective combination. By operating the country’s most During the last 78 years we comprehensive heart research program The major areas of research at the have come a long way, but still our scientists are considered to be Baker are: have much more to achieve. amongst the very best. The Baker is • The risk factors and prevention of It’s the expertise and enthusiasm of recognised internationally as one of the heart disease all our dedicated staff members that world’s leading medical research centres. • Coronary disease, heart attack and will ensure we continue to make a sudden coronary death difference. After all, health means In the past, Baker scientists have • Heart failure the world to us. discovered the medical knowledge that we • Diabetes and its complications A WORD FROM OUR PATRON Sir Laurence Muir I was fortunate to be introduced to the I remember with gratitude my first stress magazine about pets as therapy. With the Alfred Hospital and soon after the test on Garry Jennings’ (current Director help of my son-in-law Dr Edward Donelan Baker Heart Research Institute by Sir of the Baker) bicycle. Urged on by then and some other vets we set up the Delta William Philip and John Habersberger Director Paul Korner, I pushed toward Society to encourage pets as companions. over 40 years ago. For me it has been my limit only to have the machinery go an inspiring and stimulating experience haywire. Garry stopped the proceedings, Dr Warwick Anderson, then at the Baker, to serve with intelligent and highly did lots of chart analysis and then wired spent 2 years in researching the effect of motivated scientists and administrators me up for 24 hours. companion animals on our heart patients. who are dedicated to solving health The results were very favourable and the problems and helping others. Thanks to his care and concern everything veterinarians are continuing to alert the settled down and there have been no community to these advantages. The skill of our research workers has further ‘incidents’ in my 80 years. earned for the Baker a world wide The Baker is not only a world leader in reputation and the partnership with the On the journey back from the UK about medical research; it is peopled and led Alfred is a model in applied research. 20 years ago I read in the QANTAS by warm and caring Australians. 4 PRESIDENT’S REPORT Norman O’Bryan I retire from the Baker Board this year buildings, some of which were encourages scientific and social and so this will be my last President’s constructed in the very early part of interaction, because people can see one Report. I thought I should do something the 20th Century when the Baker was another and the spaces are large a little different and take the founded. The “Old Baker Building”, enough to enable research partnerships opportunity to review not only aspects as our former home is now officially and collaborations to form naturally, of the year just past, but also to give called, was a quaint and serviceable as they should do in an organisation you a few thoughts about the Baker’s collection of buildings which did not dedicated to the pursuit of scientific progress in the last decade, where I inspire anyone by their architectural and medical discovery in all of its think it is now and where I hope it will qualities and did not provide a multifarious dimensions. It is a perfect be heading in the future. stimulating or efficient working environment in which to indulge one environment. One of the ‘Old Baker’ of humankind’s greatest aspirations: Annual Reports are hard work for all building’s chief drawbacks, as I the pleasure of finding things out. involved, but a very necessary discipline perceived it, was the fact that it did not which is sensibly imposed upon most encourage collaboration of any sort Despite the fact that we are now well public organisations so that they may because all of the laboratories were and truly settled into this still very new render an account of themselves, both physically constrained and quite home, I think the challenges for the financially and in terms of performance, separate from one another. I regarded Baker remain essentially the same as by explaining what they have been it as a key priority to get the Baker those which I identified when I first doing in the past year and what they housed in better premises because I became associated with the Institute. plan to do in the near future. But it is have always believed in the motive However, our approaches to managing also a good idea from time to time to power of architecture to inspire human and overcoming them are now quite take a wider perspective on the creativity and productivity. There is different. I am pleased to say that I organisation and I shall endeavour to do ample physical and intellectual regard our approach to problem solving this in some measure here. The space evidence of this in Egypt, Greece, and strategic planning for the Baker’s allotted for me in this report is Rome, China and all across Europe. future as much more sophisticated and insufficient to give you a full survey of efficient than it was when I first all of the Baker’s activities, and anyway Probably the most exciting event that arrived. This is due in no small measure Garry Jennings will tell you about most has occurred in my time on the Baker to the combined talents and of the exciting happenings of 2004 and Board is the planning, construction and professionalism of Garry Jennings and what they portend for the future. the move into our new building. It is our senior scientists, Erica Hughes and the ideal home for an Institute like the her administration team and our Board When I first arrived at the Baker in the Baker in every respect. It is open, bright, members. This is my last public late 1980’s it was located in its old cheery and uplifting as soon as you opportunity to applaud them, which I home in Baker Lane in quite worn-out walk in the door. It also actively do wholeheartedly. www.baker.edu.au 5 Resources additional monies which would provide Tsunami, but because that salvation The most valuable and the scarcest a pool of discretionary funds in the cannot be illustrated in the graphic and resource for the Australian medical hands of the Director to devote to dramatic fashion that occurred in the research community is money. When projects which for various reasons do Tsunami Appeal, it does not resonate I arrived at the Baker it was a block not attract sufficient funding from with the Australian public sufficiently funded Institute of the NHMRC and public sources. It is of the very essence loudly to attract the funds on the scale could rely upon a fixed sum, slightly of independent medical research that given to disaster relief.
Recommended publications
  • 2007 Annual Report Annual Institute Eye Lions Review Molecular
    Lions Eye Institute ABN 48 106 521 439 2 Verdun Street, Nedlands WA 6009 General Administration & Research Enquiries 9381 0777 Administration & Research Facsimile 9381 0700 07 International +61 8 9381 0777 Clinical Facilities Elsie Gadd Eye Clinic Appointments 9381 0888 Day Surgery Facility 9381 0880 Laser Vision Centre 9381 0758 Clinical Facilities Facsimile 9382 1171 Annual REPORT 20 WWW.LEI.ORG.AU RAZOREYE LEI5693 02/08 Lions Eye Institute 2007 Annual Report Annual Report 2007 Corporate Directory Mission Lions Eye Institute Prof. Ian Constable AO Assoc. Prof. Geoffrey Crawford Administration & Finance Our mission is to achieve excellence Managing Director Director of Surgical Services [email protected] [email protected] Chee-Peng Yao in scientific research and clinical practice 9381 0871 Chief Financial Officer Esther McCloskey [email protected] to prevent blindness. Executive Assistant to Prof. Constable Assoc. Prof. Graham Barrett 9381 0703 [email protected] [email protected] 9381 0882 9381 0872 David Eiszele Dr Jean-Louis deSousa Information Technology Chairman [email protected] & Communications 9381 0777 9381 0747 Yaasin Lutta Dr Adam Gajdatsy Head of Information Technology [email protected] & Communications Research 9381 0763 [email protected] 9381 0786 Prof. P. Elizabeth Rakoczy Dr Antonio Giubilato Director of Research; [email protected] Director, Molecular Ophthalmology 9381 0819 [email protected] Lions Eye Bank 9381 0726 Dr Tim Isaacs [email protected] Stephanie Durham Coordinator Assoc. Prof. Mariapia Degli-Esposti 9381 0862 Co-Director, Centre for Experimental [email protected] Immunology; Assoc.
    [Show full text]
  • Finding Cures for Cardiovascular Disease Through World-Class Medical Research 02 VICTOR CHANG CARDIAC RESEARCH INSTITUTE IMPACT REPORT 2019 03
    IMPACT REPORT 2019 Finding cures for cardiovascular disease through world-class medical research 02 VICTOR CHANG CARDIAC RESEARCH INSTITUTE IMPACT REPORT 2019 03 For years the Victor Chang Cardiac Research Institute has Contents been Australia’s home of heart research. Since , the Institute has made an unshakeable contribution to the fight against About Us 4 Heart Disease Statistics 6 cardiovascular disease, and that PATIENT STORY SCAD Survivor 8 makes us overwhelmingly proud. Chairman’s Report 10 Executive Director’s Report 14 In ­­ we farewell our PATIENT STORY Cardiac Arrest Survivor 16 Organisational Structure 17 pioneering Executive Director, Board of Directors 18 Professor Bob Graham. 25 years of discovery 20 PROFILE Professor Bob Graham 24 Nevertheless, we are confident PROFILE Professor Diane Fatkin 34 that in Professor Jason Kovacic PROFILE Professor Livia Hool 38 Research Divisions Overview 42 we have a champion who will not Victor Chang Cardiac Research Institute Innovation Centre 44 only continue this legacy but take Sohn Hearts & Minds the Institute to the next level, as Investment Leaders Conference 46 Heart Health Checks 48 the new leader of the organisation. Statement of Income and Expenditure 49 Achievements and Awards 50 Fundraising Events 52 Supporters and Acknowledgments 54 This special 25th Anniversary edition is dedicated Support Life-Saving Heart Research 57 to you, our loyal supporters. After a quarter of a century, thanks to you, we’re only just getting started. Here’s to another 25 illustrious years! 04 VICTOR CHANG CARDIAC RESEARCH INSTITUTE IMPACT REPORT 2019 05 About Us Our Mission Our Statistics Australia’s home The relief of pain and suffering and the promotion of wellbeing, of heart research through an understanding of the fundamental The Victor Chang Cardiac Research mechanisms of researchers and staff cardiovascular biology in Institute is dedicated to finding cures health and disease.
    [Show full text]
  • Today's Research Tomorrow's Cure
    2018 Heart Research Institute Annual Review Accelerating Research Tomorrow’s cure Tomorrow’s Today’s research Today’s 2018 Heart Research Institute Annual Review Hello Future Accelerating 2018 Heart Research Institute Annual Review Research ACCELERATING Discoveries into therapies Knowledge into prevention Breakthroughs into cures Students into leaders Collaborations into partnerships 4 2018 Heart Research Institute Annual Review Inspiring Leaders 2018 Heart Research Institute Annual Review CONTENTS 06 HRI in 2018 08 Chairman’s Report 2018 10 Director of Cardiovascular Research Report 12 2018 Research and Media Highlights 16 Applied Materials Group 18 Atherosclerosis and Vascular Remodelling Group 20 Cardiac Imaging Group 22 Cardiometabolic Disease Group 24 Cardiovascular Medical Devices Group 26 Cell Therapeutics Group 28 Clinical Research Group 30 Haematology Research Group 32 Heart Rhythm and Stroke Prevention Group 34 High Blood Pressure Group 36 Thrombosis Group 38 Vascular Complications Group 40 Vascular Immunology Group 42 Inflammation and Fibrosis Research 44 PhD Students 45 Select Prizes and Awards 46 Select Conferences and Presentations 50 Select Publications 56 Board of Governors 59 International Board of Governors 60 Members of the Institute 62 Fundraising Report 66 Operations Report 6 2018 Heart Research Institute Annual Review The mission of the Heart Research Institute (HRI) is to prevent death and suffering from cardiovascular disease through an understanding of the biological processes that cause atherosclerosis and thrombosis, the major underlying causes of most heart attacks and strokes. 20 18 SHORT TERM LONG TERM The major short-term focus of our research There are four long-term objectives is to understand the development and for our research: progression of atherothrombotic conditions • To investigate mechanisms in which the arteries are narrowed and contributing to the pathogenesis restricted due to a build-up of fatty of cardiovascular disease.
    [Show full text]
  • Annual Report 2005, Baker Heart Research Institute
    Baker Heart Research Institute | Annual Report 2005 Annual Report 2005 Contents 2 The Baker story 4 Organisational Structure 6 Director’s Report 8 President’s Report 9 A word from our patron 10 The Board 12 Baker History 14 Summary of Baker relationships 15 Research & Divisions 16 Baker Clinical 17 ABMU 18 Experimental Cardiology and Heart Failure 19 Wynn Department of Cardiology 20 Cellular Biochemistry 21 Experimental Cardiology 22 Cardiac Hypertrophy 23 Cardiac Surgery 24 Applied Cardiovascular Research 25 Molecular Endocrinology 26 Molecular Pharmacology 27 Atherothrombosis and Vascular 28 Thrombosis & Myocardial Infarction 29 Cell Biology 30 Clinical Physiology 31 Vascular Pharmacology 32 Cell Biology & Diabetes 33 Lipoproteins & Atherosclerosis 34 Human & Vascular Biology 35 JDRF Diabetes and Metabolism 36 Oxidative Stress 37 Human Epigenetics 38 Biochemistry of Diabetic Complications 39 Kidney Disease in Diabetic Complications 40 Advanced Glycation in Diabetic Complications 41 Genomics of Diabetic Complications 42 Proliferation & Fibrosis in Diabetic Complications 43 Atherosclerosis in Diabetic Complications 44 Cardiovascular Neuroscience 45 Neuropharmacology 46 Translational Proteomics Ramaciotti Centre 47 Human Neurotransmitters 48 Commercialisation 60 Core Facilities 62 Staff & Students 66 Monthly Baker Science Awards 68 Development 67 Donors 70 Financial Report 73 Publications 76 Location & Contact details now in its 80th year, the Baker A comprehensive research Heart Research Institute is program with a strategic focus: The Baker story… Australia’s most distinguished Research at the Baker is broadly cardiovascular research centre divided into four divisions: and one of the world’s leading Experimental Cardiology and Heart organisations investigating Failure; Atherothrombosis and the causes and complications, Vascular; Diabetes and Metabolism treatment and prevention of heart, and Cardiovascular Neuroscience.
    [Show full text]
  • Snow Fellowship 2021 Application Round - Eligible Host Organisations
    Snow Fellowship 2021 Application Round - Eligible Host Organisations Entity name Asbestos Diseases Research Institute Australian Catholic University Limited Australian Centre for Heart Health Australian Institute of Aboriginal and Torres Strait Islander Studies Australian National University Baker Heart and Diabetes Institute Bionics Institute Black Dog Institute Bond University Limited Brien Holden Vision Institute Burnet Institute Centenary Institute of Cancer Medicine and Cell Biology Central Australian Aboriginal Congress Aboriginal Corporation Central Queensland University Centre for Eye Research Australia Limited Charles Darwin University Charles Sturt University Children's Cancer Institute Children's Medical Research Institute Chris O'Brien Lighthouse Curtin University Deakin University Doherty Institute Ear Science Institute Australia Incorporated Edith Cowan University Federation University Australia Flinders University Florey Institute of Neuroscience and Mental Health Garvan Institute of Medical Research George Institute for Global Health Griffith University Hanson Institute Harry Perkins Institute of Medical Research Heart Research Institute Hudson Institute of Medical Research Hunter Medical Research Institute Ingham Institute Institute for Breathing and Sleep James Cook University Kolling Institute of Medical Research La Trobe University Lions Eye Institute Macquarie University Snow Fellowship 2021 Application Round - Eligible Host Organisations Mater Research Limited Melanoma Institute Australia Menzies School of Health
    [Show full text]
  • Snow Fellowships 2020 Application Round - Eligible Host Organisations
    Snow Fellowships 2020 Application Round - Eligible Host Organisations Entity name Asbestos Diseases Research Institute Australian Catholic University Limited Australian Centre for Heart Health Australian Institute of Aboriginal and Torres Strait Islander Studies Australian National University Baker Heart and Diabetes Institute Bionics Institute Black Dog Institute Bond University Limited Brien Holden Vision Institute Burnet Institute Centenary Institute of Cancer Medicine and Cell Biology Central Australian Aboriginal Congress Aboriginal Corporation Central Queensland University Centre for Eye Research Australia Limited Charles Darwin University Charles Sturt University Children's Cancer Institute Children's Medical Research Institute Chris O'Brien Lighthouse Curtin University Deakin University Doherty Institute Ear Science Institute Australia Incorporated Edith Cowan University Federation University Australia Flinders University Florey Institute of Neuroscience and Mental Health Garvan Institute of Medical Research George Institute for Global Health Griffith University Hanson Institute Harry Perkins Institute of Medical Research Heart Research Institute Hudson Institute of Medical Research Hunter Medical Research Institute Ingham Institute Institute for Breathing and Sleep James Cook University Kolling Institute of Medical Research La Trobe University Lions Eye Institute Macquarie University Mater Research Limited Melanoma Institute Australia Menzies School of Health Research Monash University Murdoch Children’s Research Institute Murdoch
    [Show full text]
  • Annual Scientific Meeting of the Australian Atherosclerosis Society October 21 – 23, 2015, Fremantle, Western Australia Faculty Member Biographies
    Annual Scientific Meeting of the Australian Atherosclerosis Society October 21 – 23, 2015, Fremantle, Western Australia Faculty Member Biographies International Guest Speakers: Prof. Bart Staels, Pasteur Institute, Lille, France Prof. Bart Staels’ research focuses on molecular pharmacology of cardiovascular and metabolic diseases, including dyslipidemia and type 2 diabetes. He particularly studies the role of nuclear receptors (such as the PPARs, FXR, Rev-erba and RORa) in the control of inflammation and lipid and glucose homeostasis as well as the transcriptional mechanisms involved. Pr. Staels was among the first to identify a crucial role for the nuclear receptor PPARa in the control of lipid and glucose metabolism as well as cardiovascular function in humans. Dr Jean-Sébastien Silvestre From 1999 to 2007, he has been assistant professor at Paris-Diderot University and an honorary member of Institute Universitaire de France. Since 2008, he is research director at Institute Nationale de la Santé et de la Recherche Médicale (Inserm) and head of team 6 ‘regenerative therapies for cardiac and vascular diseases’ at the Paris Cardiovascular Research Center-Inserm UMRS 970 (Paris, France). His central interest lies in cardiovascular physiology and the role of vascular growth and remodelling in ischemic diseases. He has co-authored more than 100 published articles deciphering the molecular and cellular mechanisms involved in post-ischemic revascularization and tissue regeneration. Dr Bhama Ramkhelawon New York University Langone Medical Center Postdoctoral Fellow Bhama’s continuous eagerness to learn biological sciences brought her from Mauritius to France, where she obtained her PhD in cardiovascular diseases. She then moved to New York to gain expertise in the field of cardio-metabolic pathologies.
    [Show full text]
  • Menzies Research Institute Annual Report 2007 About Us
    Menzies Research Institute Annual Report 2007 About us At the Menzies Research Institute In 2000, the Tasmanian Government Our Research our aspiration is to contribute named Menzies a “Tasmanian Menzies’ researchers are currently significantly to improving human Icon” in recognition of our scientific working on over 100 projects that health and wellbeing. achievements, status and place in focus on preventing or curing a range the Tasmanian community. Menzies is renowned locally, nationally of diseases, including heart disease, and internationally for its research We underwent significant governance cancer, dementia, multiple sclerosis, excellence that utilises the competitive and structural changes in 2004, diabetes, cystic fibrosis, arthritis, advantages Tasmania has to offer. including a name change to the osteoporosis and mental health. Menzies Research Institute and the We are finding answers to local The research program at Menzies appointment of an independent Board. health problems that have global is organised around themes of significance. A significant ongoing growth research excellence: strategy was implemented in • Biostatistics; Tasmania is an ideal environment 2006 which saw Menzies undergo with many competitive advantages • Cancer; a dynamic transformation. We for medical research to thrive, • Cardiovascular Disease; became Tasmania’s premier medical including our small island research facility. Menzies’ research • Diabetes and Metabolism; geography, stable population, programs were expanded to focus • Genetics; extensive
    [Show full text]
  • NHMRC Administering Institutions List
    NHMRC Approved Administering Institutions This list is current as at 05 August 2020 and will be amended as required. The institutions listed below have been approved as Administering Institutions (https://nhmrc.gov.au/funding/manage-your-funding/nhmrcs-administering-institutions). Names appear as listed in NHMRC’s Research Grant Management System (RGMS). Administering Institutions are required to sign an NHMRC Funding Agreement prior to receiving any funds (https://nhmrc.gov.au/funding/manage-your-funding/funding-agreement-and-deeds-agreement) For any queries relating to approved Administering Institutions, please email [email protected]. # Entity name Australian Business Number (ABN) 1 Aboriginal Health and Medical Research Council of NSW 66085654397 2 ANZAC Research Institute 48066780055 3 Australia New Zealand Gynaecological Oncology Group 69138649028 4 Australian Catholic University Limited 15050192660 5 Australian Centre for Heart Health 87267901425 6 Australian Institute of Aboriginal and Torres Strait Islander Studies 62020533641 7 Australian National University 52234063906 8 Baker Heart and Diabetes Institute 98131762948 9 Bond University Limited 88010694121 10 Burnet Institute 49007349984 11 Cancer Council NSW 51116463846 12 Cancer Council Queensland 48321126727 13 Cancer Council Victoria 61426486715 14 Centenary Institute of Cancer Medicine and Cell Biology 22654201090 15 Central Adelaide Local Health Network Incorporated 96269526412 16 Central Australian Aboriginal Congress Aboriginal Corporation 76210591710
    [Show full text]
  • Enhancing the Commercialisation Outcomes of Health & Medical
    a Enhancing the commercialisation outcomes of health & medical research Supplementary submission to the Strategic Review of Health & Medical Research by the Association of Australian Medical Research Institutes (AAMRI) JULY / 2012 AAMRI / Supplementary submission to the McKeon Review COVER IMAGE: ©iStockphoto.com/askinkamberoglu AAMRI / Supplementary submission to the McKeon Review i Foreword The following submission is in response to a request from the McKeon Review Panel for ideas on how to increase the levels of commercially sponsored translation of Australian health and medical research. Partnership of researchers with commercial interests, including investors, venture capitalists and fund managers, as well as drug and device developers, is essential if patients are to benefit from the outcomes of health and medical research. In constructing this submission, AAMRI has therefore sought input from across the entire commercialisation ‘pipeline’. A round table discussion was held at the Baker IDI Heart and Diabetes Institute on Thursday 14 June 2012 to explore these issues. While this submission represents AAMRI’s interpretation of those discussions, all efforts have been made to represent and integrate the ideas and views of meeting participants. Round table participants > Anna-Maria Arabia, CEO, Science & Technology Australia > Dr Julian Clark, Head, Business Development, Walter & Eliza Hall Institute of Medical Research > Dr Nicole den Elzen, Executive Officer, Association of Australian Medical Research Institutes > Dr Leigh Farrell,
    [Show full text]
  • Annual Report | 2014
    Community A society that is well informed and values the benefits of health and medical research Investment Greater investment in health and medical research from all sources Prosperity Ensure Australia captures the benefits of health and medical research Position Promote Australia’s global position in health and medical research Mission To make health and medical research a higher priority for the nation Published November 2014 2 Board of Directors Research Australia’s Board reflects a balanced and effective governance structure. The membership contains technical expertise drawn from medical industry associations, medical research institutes, universities and philanthropic foundations, and companies. This technical expertise is complemented by members who bring professional expertise from business, finance, law, consumer advocacy, public policy and philanthropy. Chair Professor Janet Hiller Dean, School of Health Sciences, Professor Christine Bennett AO Swinburne University of Technology Dean of the School of Medicine, Sydney, Notre Dame University Mr Geoff Joyce Executive Director, Macquarie Capital Deputy Chair Mr Peter Wills AC Dr Anna Lavelle Respected research advocate CEO, AusBiotech Professor John McGrath Queensland Centre for Mental Health Ms Elizabeth Foley Research & Professor, Queensland Brain Managing Director, Institute, University of Queensland Research Australia Ltd Professor Alexandra McManus Dr Alison Butt Director, Centre of Excellence for Science Director, Research Investment, National Seafood & Health, Curtin University
    [Show full text]
  • Download a Pdf Version of the 2017 Convention Program
    2017 ANNUAL CONVENTION 6&7 December Hotel Realm 18 National Circuit, Barton, ACT AAMRI MEMBERS EVENT CONTACTS Peter Thomas, 0411 600 992, [email protected] Kathryn Naumenko, 0402 117 529, [email protected] Cath Latham, 0413 865 459, [email protected] 2 CONVENTION PROGRAM WED 6 DEC 9.00am REGISTRATION OPENS 9.30am-12.30pm MRI BUSINESS MANAGERS’ MEETING Pages 7-14 National Ballroom 2, Hotel Realm Canberra 12.30pm-1.30pm LUNCH National Ballroom 1, Hotel Realm Canberra 1.30pm-5.00pm AAMRI STRATEGY MEETING Pages 15-22 National Ballroom 2, Hotel Realm Canberra 5.30pm-6.30pm MRI BOARD MEMBER PRE-DINNER DRINKS High Courtyard South, Hotel Realm Canberra 6.30pm COURTESY BUSES FROM HOTEL REALM TO PARLIAMENT HOUSE Depart from the rear of Hotel Realm, in Burbury Close 7.00pm 2017 AAMRI ANNUAL DINNER Great Hall, Parliament House Guest speaker: The Hon Greg Hunt MP, Minister for Health, Minister for Sport 10.15PM Courtesy bus from Parliament House to Hotel Realm Canberra THURS 7 DEC 7.30am-8.30am AAMRI PRESIDENT’S BREAKFAST National Ballroom 2, Hotel Realm Canberra Guest speaker: The Hon Bill Shorten MP, Leader of the Opposition 8.45am-11.00am AAMRI AGM (REGISTRATION FROM 8.30AM) Pages 23-27 National Ballroom 2, Hotel Realm Canberra 3 PARTICIPANTS Mr Peter Allen Board Chair Wesley Medical Research Ms Gina Anderson Board Member The George Institute for Global Health Mr Richard Balderstone Board Olivia Newton-John Cancer Research Institute Dr Johanna Barclay Research Development Manager Mater Medical Research Institute Mr
    [Show full text]